Dorresteijn JA - Search Results

1

Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy.

van der Sande NG, Dorresteijn JA, Visseren FL, Dwyer JP, Blankestijn PJ, van der Graaf Y, Heerspink HL. van der Sande NG, et al. Among authors: dorresteijn ja. Diabetes Obes Metab. 2016 Nov;18(11):1120-1127. doi: 10.1111/dom.12708. Epub 2016 Aug 12. Diabetes Obes Metab. 2016. PMID: 27337598

2

Mechanisms linking obesity to hypertension.

Dorresteijn JA, Visseren FL, Spiering W. Dorresteijn JA, et al. Obes Rev. 2012 Jan;13(1):17-26. doi: 10.1111/j.1467-789X.2011.00914.x. Epub 2011 Aug 10. Obes Rev. 2012. PMID: 21831233 Review.

3

Estimating treatment effects for individual patients based on the results of randomised clinical trials.

Dorresteijn JA, Visseren FL, Ridker PM, Wassink AM, Paynter NP, Steyerberg EW, van der Graaf Y, Cook NR. Dorresteijn JA, et al. BMJ. 2011 Oct 3;343:d5888. doi: 10.1136/bmj.d5888. BMJ. 2011. PMID: 21968126 Free PMC article. Clinical Trial.

4

Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited.

Dorresteijn JA, van der Graaf Y, Spiering W, Grobbee DE, Bots ML, Visseren FL; Secondary Manifestations of Arterial Disease Study Group. Dorresteijn JA, et al. Hypertension. 2012 Jan;59(1):14-21. doi: 10.1161/HYPERTENSIONAHA.111.179143. Epub 2011 Nov 7. Hypertension. 2012. PMID: 22068865

5

Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects.

Dorresteijn JA, Visseren FL, Ridker PM, Paynter NP, Wassink AM, Buring JE, van der Graaf Y, Cook NR. Dorresteijn JA, et al. Eur Heart J. 2011 Dec;32(23):2962-9. doi: 10.1093/eurheartj/ehr423. Epub 2011 Nov 16. Eur Heart J. 2011. PMID: 22090661 Free PMC article. Clinical Trial.

6

Patient education for preventing diabetic foot ulceration.

Dorresteijn JA, Valk GD. Dorresteijn JA, et al. Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:101-6. doi: 10.1002/dmrr.2237. Diabetes Metab Res Rev. 2012. PMID: 22271733 Free article. Review.

7

Relation between adiposity and hypertension persists after onset of clinically manifest arterial disease.

Dorresteijn JA, Spiering W, Van Der Graaf Y, Visseren FL; SMART Study Group. Dorresteijn JA, et al. J Hypertens. 2012 Dec;30(12):2331-7. doi: 10.1097/HJH.0b013e328357f18a. J Hypertens. 2012. PMID: 23041751

8

Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial.

Dorresteijn JA, Schrover IM, Visseren FL, Scheffer PG, Oey PL, Danser AH, Spiering W. Dorresteijn JA, et al. J Hypertens. 2013 Feb;31(2):393-403. doi: 10.1097/HJH.0b013e32835b6c02. J Hypertens. 2013. PMID: 23235355 Clinical Trial.

9

The daily 10 kcal expenditure deficit: a before-and-after study on low-cost interventions in the work environment.

Dorresteijn JA, van der Graaf Y, Zheng K, Spiering W, Visseren FL. Dorresteijn JA, et al. BMJ Open. 2013 Jan 24;3(1):e002125. doi: 10.1136/bmjopen-2012-002125. BMJ Open. 2013. PMID: 23355669 Free PMC article.

10

Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score.

Dorresteijn JA, Visseren FL, Wassink AM, Gondrie MJ, Steyerberg EW, Ridker PM, Cook NR, van der Graaf Y; SMART Study Group. Dorresteijn JA, et al. Heart. 2013 Jun;99(12):866-72. doi: 10.1136/heartjnl-2013-303640. Epub 2013 Apr 10. Heart. 2013. PMID: 23574971

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters